EP1853544A4 - TRANSCAROTENOIDS AND THEIR SYNTHESIS, THEIR PREPARATION AND USES THEREOF - Google Patents
TRANSCAROTENOIDS AND THEIR SYNTHESIS, THEIR PREPARATION AND USES THEREOFInfo
- Publication number
- EP1853544A4 EP1853544A4 EP06758166A EP06758166A EP1853544A4 EP 1853544 A4 EP1853544 A4 EP 1853544A4 EP 06758166 A EP06758166 A EP 06758166A EP 06758166 A EP06758166 A EP 06758166A EP 1853544 A4 EP1853544 A4 EP 1853544A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- formulation
- synthesis
- trans carotenoids
- carotenoids
- trans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 235000021466 carotenoid Nutrition 0.000 title 1
- 150000001747 carotenoids Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/602—Dicarboxylic acid esters having at least two carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/04—Sodium compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12166293.6A EP2540696B1 (en) | 2005-02-24 | 2006-02-24 | Trans carotenoids, formulation and uses |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65542205P | 2005-02-24 | 2005-02-24 | |
PCT/US2006/006422 WO2006104610A2 (en) | 2005-02-24 | 2006-02-24 | Trans carotenoids, their synthesis, formulation and uses |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12166293.6A Division EP2540696B1 (en) | 2005-02-24 | 2006-02-24 | Trans carotenoids, formulation and uses |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1853544A2 EP1853544A2 (en) | 2007-11-14 |
EP1853544A4 true EP1853544A4 (en) | 2010-06-16 |
Family
ID=37053852
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12166293.6A Active EP2540696B1 (en) | 2005-02-24 | 2006-02-24 | Trans carotenoids, formulation and uses |
EP06758166A Withdrawn EP1853544A4 (en) | 2005-02-24 | 2006-02-24 | TRANSCAROTENOIDS AND THEIR SYNTHESIS, THEIR PREPARATION AND USES THEREOF |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12166293.6A Active EP2540696B1 (en) | 2005-02-24 | 2006-02-24 | Trans carotenoids, formulation and uses |
Country Status (17)
Country | Link |
---|---|
US (5) | US8030350B2 (zh) |
EP (2) | EP2540696B1 (zh) |
JP (5) | JP2008531582A (zh) |
KR (1) | KR101315904B1 (zh) |
CN (2) | CN101180257A (zh) |
AU (1) | AU2006229688B2 (zh) |
BR (1) | BRPI0608561A2 (zh) |
CA (1) | CA2598882C (zh) |
EA (1) | EA017982B1 (zh) |
ES (1) | ES2780200T3 (zh) |
IL (1) | IL185460A (zh) |
MX (1) | MX2007010359A (zh) |
NO (1) | NO20074856L (zh) |
NZ (1) | NZ561664A (zh) |
UA (1) | UA95903C2 (zh) |
WO (1) | WO2006104610A2 (zh) |
ZA (1) | ZA200707712B (zh) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ535323A (en) * | 2002-02-25 | 2008-02-29 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
UA95903C2 (ru) | 2005-02-24 | 2011-09-26 | Дифьюжен Фармасьютикалз Ллк | Транс-каротиноиды, их синтез, лекарственная форма и применение |
JP2010524855A (ja) * | 2007-04-13 | 2010-07-22 | ディフュージョン・ファーマシューティカルズ・エルエルシー | 末梢血管疾患の前処置としての、及びその処置における双極性トランスカロテノイドの使用 |
CN101878040A (zh) * | 2007-10-31 | 2010-11-03 | 扩散药品有限公司 | 一类促进小分子扩散的新型治疗剂 |
CN101157645B (zh) * | 2007-11-27 | 2010-06-02 | 江南大学 | 一种藏红花酸的合成方法 |
CN102177164B (zh) * | 2008-11-05 | 2015-02-11 | 科莱恩金融(Bvi)有限公司 | 利用烯丙醇/丙烯醛制备二烷基次膦酸、二烷基次膦酸酯和二烷基次膦酸盐的方法,以及它们的用途 |
DE102008055914A1 (de) * | 2008-11-05 | 2010-05-06 | Clariant International Limited | Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acroleinen und ihre Verwendung |
DE102008055916A1 (de) * | 2008-11-05 | 2010-05-06 | Clariant International Limited | Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Allylalkoholen und ihre Verwendung |
DE102008056339A1 (de) * | 2008-11-07 | 2010-05-12 | Clariant International Limited | Verfahren zur Herstellung von mono-aminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung |
DE102008056341A1 (de) * | 2008-11-07 | 2010-05-12 | Clariant International Limited | Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung |
DE102008056342A1 (de) * | 2008-11-07 | 2010-05-12 | Clariant International Limited | Verfahren zur Herstellung von Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung |
EP2352740B1 (de) * | 2008-11-07 | 2014-09-24 | Clariant Finance (BVI) Limited | Verfahren zur herstellung von dialkylphosphinsäuren, -estern und -salzen mittels acrylsäurederivaten und ihre verwendung |
CN102171226B (zh) | 2008-11-11 | 2015-02-11 | 科莱恩金融(Bvi)有限公司 | 利用烯丙基化合物制备单烯丙基官能化的二烷基次膦酸、其盐或酯的方法以及它们的用途 |
DE102008060036A1 (de) * | 2008-12-02 | 2010-06-10 | Clariant International Limited | Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung |
DE102008060035A1 (de) * | 2008-12-02 | 2010-06-10 | Clariant International Limited | Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung |
DE102008060535A1 (de) * | 2008-12-04 | 2010-06-10 | Clariant International Limited | Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylether und ihre Verwendung |
ES2446666T3 (es) | 2008-12-18 | 2014-03-10 | Clariant Finance (Bvi) Limited | Procedimiento para la preparación de ácidos etilen-dialquil-fosfínicos, o de sus ésteres y sales, mediante acetileno, y su utilización |
DE102008063642A1 (de) * | 2008-12-18 | 2010-06-24 | Clariant International Limited | Verfahren zur Herstellung von monocarboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Alkylenoxiden und ihre Verwendung |
DE102008063627A1 (de) | 2008-12-18 | 2010-06-24 | Clariant International Limited | Verfahren zur Herstellung von monohydroxyfunktionalisierten Dialkylphosphinsäuren,-estern und -salzen mittels Ethylenoxid und ihre Verwendung |
DE102008063668A1 (de) | 2008-12-18 | 2010-07-01 | Clariant International Limited | Verfahren zur Herstellung von Alkylphosponsäuren, -estern und -salzen mittels Oxidation von Alkylphosphonigsäuren und ihre Verwendung |
DE102008064012A1 (de) | 2008-12-19 | 2010-06-24 | Clariant International Limited | Halogenfreie Addukte von Alkylphosphonigsäurederivaten und diesterbildenden Olefinen, halogenfreie Verfahren zu deren Herstellung und ihre Verwendung |
DE102008064003A1 (de) | 2008-12-19 | 2010-06-24 | Clariant International Limited | Verfahren zur Herstellung von mono-funktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung |
CN108464976A (zh) | 2009-06-22 | 2018-08-31 | 扩散药品有限公司 | 扩散促进化合物及其单独或与溶栓药一起的应用 |
EP2575487B1 (en) * | 2010-06-02 | 2017-10-18 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
CN102372623A (zh) * | 2010-08-27 | 2012-03-14 | 江苏天晟药业有限公司 | 藏红花酸二铵盐 |
US10155715B2 (en) | 2010-11-02 | 2018-12-18 | The United States Of America As Represented By The Department Of Veterans Affairs | Purified crocetin compound and method for treating, inhibiting, and/or prophylaxis of cancer, such as pancreatic cancer |
US9889105B2 (en) | 2010-11-02 | 2018-02-13 | U.S. Department Of Veterans Affairs | In vivo method for treating, inhibiting, and/or prophylaxis of cancer, such as pancreatic cancer |
US10463066B2 (en) * | 2012-05-15 | 2019-11-05 | Tate & Lyle Ingredients Americas Llc | Process for preparing inhibited non-pregelatinized granular starches |
CN115089569A (zh) * | 2016-03-24 | 2022-09-23 | 扩散药品有限公司 | 双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途 |
JP6603815B2 (ja) * | 2017-11-21 | 2019-11-06 | 積水化学工業株式会社 | 皮膚外用剤 |
KR102133791B1 (ko) * | 2019-02-20 | 2020-07-14 | 명지대학교 산학협력단 | 노르빅신 또는 빅신 에틸 에스테르를 제조하기 위한 신규한 중간체 화합물 및 이의 제조방법 |
EP4054637A4 (en) * | 2019-11-06 | 2023-12-20 | L.E.A.F Holdings Group LLC | CAROTINOID COMPOSITIONS AND USES THEREOF |
WO2021207566A1 (en) * | 2020-04-09 | 2021-10-14 | L.E.A.F. Holdings Group Llc | Carotenoid solutions and uses thereof |
WO2023081779A1 (en) * | 2021-11-03 | 2023-05-11 | Diffusion Pharmaceuticals Llc | Crystalline forms of a diffusion enhancing compound |
WO2024006901A1 (en) * | 2022-06-29 | 2024-01-04 | Diffusion Pharmaceuticals Llc | Uses of bipolar trans carotenoids in the treatment of cancer |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3489806A (en) * | 1967-01-19 | 1970-01-13 | Hoffmann La Roche | Isoprenoid compounds and a process for producing the same |
US3687990A (en) * | 1966-01-28 | 1972-08-29 | Hoffmann La Roche | Isoprenoid compounds and a process for producing the same |
US3965261A (en) * | 1975-04-29 | 1976-06-22 | University Of Virginia | Method for treating papillomas |
US6060511A (en) * | 1995-10-05 | 2000-05-09 | Gainer; John L. | Trans-sodium crocetinate, methods of making and methods of use thereof |
US6150561A (en) * | 1997-10-03 | 2000-11-21 | Roche Vitamins Inc. | Method of making carotenoids |
WO2003072734A2 (en) * | 2002-02-25 | 2003-09-04 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
Family Cites Families (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2948748A (en) * | 1960-08-09 | Esters thereof | ||
CA100033A (en) | 1906-06-22 | 1906-07-17 | James Licurges Coldiron | Baling press |
US2175843A (en) | 1936-06-26 | 1939-10-10 | Winthrop Chem Co Inc | Polyene carboxylic acids and esters and manufacture thereof |
CH522572A (de) * | 1969-10-31 | 1972-06-30 | Hoffmann La Roche | Verfahren zur Herstellung von Polyenverbindungen |
US3788468A (en) | 1973-05-01 | 1974-01-29 | Univ Virginia | Process for increasing oxygen diffusivity |
US3853993A (en) | 1973-05-01 | 1974-12-10 | Univ Virginia | Process for increasing oxygen diffusivity and method for treating atherosclerosis |
US3853933A (en) | 1974-01-14 | 1974-12-10 | Gen Electric | Continuous process for producing polysiloxane oils utilizing a carbon black catalyst |
DE2505869C3 (de) * | 1975-02-12 | 1978-05-18 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von symmetrischen Carotinoiden |
US3975519A (en) | 1975-06-09 | 1976-08-17 | University Of Virginia | Method for increasing the oxygen partial pressure in the bloodstream of mammals |
US4070460A (en) | 1975-11-10 | 1978-01-24 | University Of Virginia Patents Foundation | Method for treating cerebral edema |
US4009270A (en) | 1975-11-21 | 1977-02-22 | The University Of Virginia | Method for treating spinal cord injury |
US4038144A (en) * | 1976-04-19 | 1977-07-26 | The University Of Virginia | Method of increasing fermentation yields |
US4046880A (en) * | 1976-04-20 | 1977-09-06 | The University Of Virginia | Method of treating hypertension |
US4099270A (en) | 1977-02-16 | 1978-07-11 | Jabour Richard J | Slip-on rubber gloves |
US4216211A (en) | 1977-10-31 | 1980-08-05 | The Procter & Gamble Company | Therapeutic composition |
US4176179A (en) | 1978-04-17 | 1979-11-27 | The University Of Virginia Alumni Patents Foundation | Method for treating arthritis |
US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
US4699664A (en) | 1985-05-01 | 1987-10-13 | Nestec S.A. | Stabilized natural pigment complexes |
US5032613A (en) | 1986-02-12 | 1991-07-16 | W. Keith R. Watson | Method and composition for treating arthritis |
JPH0661211B2 (ja) | 1986-08-29 | 1994-08-17 | 花王株式会社 | パン用改質剤、パン生地及びパンの製造方法 |
US4781676A (en) * | 1987-02-20 | 1988-11-01 | Air Products And Chemicals, Inc. | Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells |
US5811119A (en) * | 1987-05-19 | 1998-09-22 | Board Of Regents, The University Of Texas | Formulation and use of carotenoids in treatment of cancer |
US5084274A (en) | 1987-11-17 | 1992-01-28 | Scripps Clinic And Research Foundation | Inhibition of arterial thrombotic occlusion or thromboembolism |
US5472946A (en) | 1988-04-08 | 1995-12-05 | Peck; James V. | Transdermal penetration enhancers |
GB8822147D0 (en) | 1988-09-21 | 1988-10-26 | Ciba Geigy Ag | Pharmaceutically active combination |
FR2647343B1 (fr) | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | Nouvelle forme pharmaceutique poreuse et sa preparation |
IT1233303B (it) | 1989-06-07 | 1992-03-26 | Azionaria Costruzioni Acma Spa | Apparecchiatura per il convogliamento di prodotti |
US5053240A (en) | 1989-10-24 | 1991-10-01 | Kalamazoo Holdings, Inc. | Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides |
JPH04264020A (ja) * | 1991-02-18 | 1992-09-18 | Yamanouchi Pharmaceut Co Ltd | 安定な凍結乾燥製剤 |
US5107030A (en) | 1991-03-04 | 1992-04-21 | Loyola University Of Chicago | Method of making 2,7-dimethyl-2,4,6-octatrienedial and derivatives thereof |
JP3176716B2 (ja) | 1991-06-21 | 2001-06-18 | 武田薬品工業株式会社 | 溶解性が向上した難水溶性薬物組成物 |
JP2977961B2 (ja) | 1991-07-26 | 1999-11-15 | 株式会社資生堂 | 化粧料 |
JPH06248193A (ja) | 1993-02-25 | 1994-09-06 | Ensuiko Sugar Refining Co Ltd | クロセチン含有着色料 |
IL110139A0 (en) | 1993-06-28 | 1994-10-07 | Howard Foundation | Pharmaceutically-active antioxidants |
JPH0723736A (ja) | 1993-06-30 | 1995-01-27 | Taishiyoo Technos:Kk | カロチノイド色素の可溶化方法 |
JP2704356B2 (ja) | 1994-02-08 | 1998-01-26 | 正和薬品株式会社 | 脳機能改善剤 |
JPH07291854A (ja) | 1994-04-26 | 1995-11-07 | Tanabe Seiyaku Co Ltd | 溶解性の改善された医薬品製剤 |
US5576287A (en) | 1994-04-29 | 1996-11-19 | Wake Forest University | Method for treating acute renal disease and failure |
GB2290964A (en) | 1994-07-08 | 1996-01-17 | Arto Olavi Urtti | Transdermal drug delivery system |
US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
RU2107496C1 (ru) | 1997-02-10 | 1998-03-27 | Российская медицинская академия последипломного образования Министерства здравоохранения РФ | Способ лечения диабетической ангиопатии |
JPH1119261A (ja) | 1997-07-01 | 1999-01-26 | Takenaka Komuten Co Ltd | 低圧トレーニング施設 |
JPH1129466A (ja) | 1997-07-09 | 1999-02-02 | Lion Corp | 水性皮膚外用剤 |
US6391336B1 (en) | 1997-09-22 | 2002-05-21 | Royer Biomedical, Inc. | Inorganic-polymer complexes for the controlled release of compounds including medicinals |
JPH11209642A (ja) | 1998-01-27 | 1999-08-03 | Taito Kk | アナトー色素製剤及びその製造方法 |
US6235311B1 (en) | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
JP2000007570A (ja) | 1998-06-24 | 2000-01-11 | Hayashibara Biochem Lab Inc | 抗内分泌障害剤 |
CN1243120A (zh) | 1998-07-23 | 2000-02-02 | 云南省烟草工业研究所 | 类胡萝卜素诱导剂2-二氨基乙基-4-甲苯基醚盐的合成方法及其在烟草中的应用 |
MA25590A1 (fr) | 1998-09-14 | 2002-12-31 | Inhale Therapeutic Syst | Agent actif de delivraison de poudre seche |
BE1012495A3 (fr) | 1999-03-02 | 2000-11-07 | Messadek Jallal | La glycine-betaine pour son usage antithrombotique. |
AU6912500A (en) | 1999-08-25 | 2001-03-19 | Gmp Companies, Inc. | Enhanced oxygen delivery in mammals, methods and reagents related thereto |
GB2353934A (en) | 1999-09-09 | 2001-03-14 | British Sugar Plc | Nutritional compositions comprising trehalose for persons suffering from diabetes |
JP2001302517A (ja) | 2000-04-24 | 2001-10-31 | Tokyo Univ Of Pharmacy & Life Science | 脳浮腫の予防治療薬 |
AU781975B2 (en) | 2000-09-14 | 2005-06-23 | Hayashibara Co., Ltd | Pharmaceutical composition for ophthalmic use |
JP5041565B2 (ja) | 2001-05-25 | 2012-10-03 | 富士化学工業株式会社 | 安定なアスタキサンチンとγ−シクロデキストリンとの包接化合物及びその製造方法、並びに液剤、飲食物、飼料、医薬品及び化粧品用途 |
EP1269994A3 (en) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
JP2003201238A (ja) | 2001-12-03 | 2003-07-18 | Yamanouchi Pharmaceut Co Ltd | 脳梗塞治療用医薬組成物 |
WO2003059270A2 (en) | 2002-01-15 | 2003-07-24 | Eli Lilly And Company | Method for reducing morbidity and mortality in critically ill patients |
BE1015608A6 (fr) | 2003-07-15 | 2005-06-07 | Messadek Jallal | Traitement des arterites. |
US7759506B2 (en) * | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
US20030180281A1 (en) | 2002-03-11 | 2003-09-25 | Bott Richard R. | Preparations for topical skin use and treatment |
US20030180282A1 (en) | 2002-03-25 | 2003-09-25 | Victor Serebruany | Method of treatment of thrombotic events |
RU2226096C1 (ru) | 2002-07-01 | 2004-03-27 | Санкт-Петербургский государственный научно-исследовательский институт скорой помощи им. И.И.Джанелидзе | Способ лечения последствий тканевой гипоксии у пациентов в критическом состоянии |
WO2004005353A1 (en) * | 2002-07-04 | 2004-01-15 | Poltec As | Complexes of cyclodextrins and carotenoids |
AU2003256982A1 (en) | 2002-07-29 | 2004-02-16 | Cardax Pharmaceuticals, Inc. | Structural carotenoid analogs for the inhibition and amelioration of disease |
US7521584B2 (en) | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
US7001893B2 (en) * | 2002-10-28 | 2006-02-21 | Council Of Scientific And Industrial Research | Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof |
DE10254809A1 (de) | 2002-11-22 | 2004-06-03 | Basf Ag | Verfahren zur Herstellung von Carotinoiden |
ATE487494T1 (de) | 2002-11-25 | 2010-11-15 | Jallal Messadek | Betain und salicylsäure zusammensetzungen |
US20040109920A1 (en) | 2002-12-04 | 2004-06-10 | Bioactives Llc | Coated carotenoid cyclodextrin complexes |
EP2292239A3 (en) | 2003-04-18 | 2011-03-30 | Advanced Medicine Research Institute | Remedies for diseases to be applied to eye |
US20070166339A1 (en) | 2003-04-18 | 2007-07-19 | Bioderm Research | Skin Whitening Methods and Compositions Based on Zeolite - Active Oxygen Donor Complexes |
BRPI0409865A (pt) | 2003-05-02 | 2006-05-16 | Paion Deutschland Gmbh | injeção intravenosa de ativadores de plasminogênio não neurotóxicos para o tratamento do ataque de apoplexia |
CN1243120C (zh) | 2003-08-02 | 2006-02-22 | 宜兴市兴达合金材料厂 | 一种超薄高平整度钼片加工方法 |
JP2005053841A (ja) | 2003-08-05 | 2005-03-03 | Kyouto Biomedical Science:Kk | 皮膚外用剤 |
WO2005028411A1 (en) * | 2003-08-25 | 2005-03-31 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
RU2265434C2 (ru) | 2003-09-30 | 2005-12-10 | Государственное учреждение Научно-исследовательский Институт Общей реаниматологии Российской Академии Медицинских Наук (ГУ НИИ ОР РАМН) | Способ лечения острого респираторного дистресс-синдрома |
RU2256446C1 (ru) | 2003-10-22 | 2005-07-20 | Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова | Способ профилактики метастазов после хирургического удаления внутриглазных новообразований |
US7446101B1 (en) | 2003-12-12 | 2008-11-04 | Bioactives, Llc | Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems |
BRPI0512040A (pt) | 2004-06-14 | 2008-02-06 | Zoser B Salama | composição farmacêutica, método de modificação de receptores de célula de tumor, método de aperfeiçoar seletividade alvo de anticorpos, método de tratar cáncer, kit, uso de prolina |
JP4514114B2 (ja) | 2004-06-18 | 2010-07-28 | ヤマハ発動機株式会社 | コイル可動形リニアモータおよび単軸ロボット |
EP2444071A1 (en) * | 2004-09-27 | 2012-04-25 | Sigmoid Pharma Limited | Minicapsule formulations |
US20060155150A1 (en) | 2004-10-01 | 2006-07-13 | Lockwood Samuel F | Methods for the synthesis of lutein |
CN101223184B (zh) | 2005-01-31 | 2012-10-10 | 麦兰实验室公司 | 葡糖苷酸化的奈必洛尔 |
US20090176287A1 (en) * | 2005-02-24 | 2009-07-09 | Regents Of The University Of Minnesota | Producing carotenoids |
UA95903C2 (ru) | 2005-02-24 | 2011-09-26 | Дифьюжен Фармасьютикалз Ллк | Транс-каротиноиды, их синтез, лекарственная форма и применение |
EP2329825B1 (en) | 2005-03-04 | 2015-10-07 | Sucampo AG | Method and composition for treating peripheral vascular diseases |
CA2606329A1 (en) * | 2005-03-09 | 2006-09-21 | Cardax Pharmaceuticals, Inc. | Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders |
US20060281724A1 (en) | 2005-06-08 | 2006-12-14 | Loria Roger M | Methods for Treating Shock |
JP2006342108A (ja) | 2005-06-09 | 2006-12-21 | Mitsubishi Chemicals Corp | アミロスフェロイドにより発生する疾患の予防治療剤 |
WO2007028167A2 (en) | 2005-09-02 | 2007-03-08 | Iomai Corporation | Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs and uses thereof |
US20070135521A1 (en) | 2005-12-14 | 2007-06-14 | Yamaha Hatsudoki Kabushiki Kaisha | Agent for Preventing Metabolic Syndrome |
ITMI20052486A1 (it) | 2005-12-23 | 2007-06-24 | Italiana Sint Spa | Procedimento di sintesi di intermedi per la preparazione di astaxantina |
US20090169586A1 (en) * | 2006-03-24 | 2009-07-02 | Ian Simon Tracton | Stable packaged dosage form and process therefor |
CN100571707C (zh) | 2006-07-24 | 2009-12-23 | 凌沛学 | 含有海藻糖的关节腔内注射给药制剂 |
ZA200900957B (en) | 2006-08-29 | 2010-05-26 | Genentech Inc | Use of tenecteplase for treating acute ischemic stroke |
CN101646442B (zh) | 2007-02-23 | 2013-09-04 | 21世纪国际新技术株式会社 | 血管痉挛的治疗剂或预防剂 |
JP2010524855A (ja) | 2007-04-13 | 2010-07-22 | ディフュージョン・ファーマシューティカルズ・エルエルシー | 末梢血管疾患の前処置としての、及びその処置における双極性トランスカロテノイドの使用 |
WO2008135090A1 (en) | 2007-05-07 | 2008-11-13 | Evonik Röhm Gmbh | Solid dosage forms comprising an enteric coating with accelerated drug release |
CN101878040A (zh) | 2007-10-31 | 2010-11-03 | 扩散药品有限公司 | 一类促进小分子扩散的新型治疗剂 |
US20090118227A1 (en) | 2007-11-07 | 2009-05-07 | Bristol-Myers Squibb Company | Carotenoid-containing compositions and methods |
WO2009111688A2 (en) | 2008-03-06 | 2009-09-11 | Wisconsin Alumni Research Foundation | All-trans retinoid esters as active pharmaceutical ingredients, oral and topical dosage form compositions thereof, and methods of treating skin conditions thereof |
CN108464976A (zh) | 2009-06-22 | 2018-08-31 | 扩散药品有限公司 | 扩散促进化合物及其单独或与溶栓药一起的应用 |
US20110035256A1 (en) | 2009-08-05 | 2011-02-10 | Roy Shkedi | Systems and methods for prioritized selection of media properties for providing user profile information used in advertising |
JP2010090151A (ja) * | 2009-12-09 | 2010-04-22 | Diffusion Pharmaceuticals Llc | 双極性トランスカロテノイド塩及びそれらの使用 |
EP2575487B1 (en) | 2010-06-02 | 2017-10-18 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
CN115089569A (zh) | 2016-03-24 | 2022-09-23 | 扩散药品有限公司 | 双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途 |
CN106100033A (zh) | 2016-07-01 | 2016-11-09 | 李红彪 | 一种可检测和滤除谐波的充电桩系统 |
-
2006
- 2006-02-24 UA UAA200710450A patent/UA95903C2/ru unknown
- 2006-02-24 WO PCT/US2006/006422 patent/WO2006104610A2/en active Application Filing
- 2006-02-24 JP JP2007557157A patent/JP2008531582A/ja active Pending
- 2006-02-24 BR BRPI0608561-0A patent/BRPI0608561A2/pt not_active IP Right Cessation
- 2006-02-24 MX MX2007010359A patent/MX2007010359A/es active IP Right Grant
- 2006-02-24 EP EP12166293.6A patent/EP2540696B1/en active Active
- 2006-02-24 NZ NZ561664A patent/NZ561664A/en unknown
- 2006-02-24 CN CNA2006800136630A patent/CN101180257A/zh active Pending
- 2006-02-24 EA EA200701799A patent/EA017982B1/ru not_active IP Right Cessation
- 2006-02-24 KR KR1020077021197A patent/KR101315904B1/ko active IP Right Grant
- 2006-02-24 ES ES12166293T patent/ES2780200T3/es active Active
- 2006-02-24 AU AU2006229688A patent/AU2006229688B2/en active Active
- 2006-02-24 CA CA2598882A patent/CA2598882C/en active Active
- 2006-02-24 CN CN201510128602.XA patent/CN104840455A/zh active Pending
- 2006-02-24 EP EP06758166A patent/EP1853544A4/en not_active Withdrawn
- 2006-02-24 US US11/361,054 patent/US8030350B2/en not_active Expired - Fee Related
-
2007
- 2007-08-22 IL IL185460A patent/IL185460A/en active IP Right Grant
- 2007-09-07 ZA ZA200707712A patent/ZA200707712B/xx unknown
- 2007-09-24 NO NO20074856A patent/NO20074856L/no not_active Application Discontinuation
-
2009
- 2009-12-02 JP JP2009274859A patent/JP2010077154A/ja active Pending
-
2011
- 2011-08-05 US US13/137,324 patent/US20120095099A1/en not_active Abandoned
- 2011-09-26 JP JP2011209754A patent/JP5719267B2/ja active Active
-
2015
- 2015-01-23 JP JP2015011575A patent/JP6088558B2/ja active Active
-
2016
- 2016-01-11 US US14/993,047 patent/US9950067B2/en active Active
- 2016-10-20 JP JP2016206140A patent/JP6799434B2/ja active Active
-
2018
- 2018-03-20 US US15/926,709 patent/US11278621B2/en active Active
-
2022
- 2022-01-31 US US17/649,530 patent/US20220387589A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3687990A (en) * | 1966-01-28 | 1972-08-29 | Hoffmann La Roche | Isoprenoid compounds and a process for producing the same |
US3489806A (en) * | 1967-01-19 | 1970-01-13 | Hoffmann La Roche | Isoprenoid compounds and a process for producing the same |
US3965261A (en) * | 1975-04-29 | 1976-06-22 | University Of Virginia | Method for treating papillomas |
US6060511A (en) * | 1995-10-05 | 2000-05-09 | Gainer; John L. | Trans-sodium crocetinate, methods of making and methods of use thereof |
US6150561A (en) * | 1997-10-03 | 2000-11-21 | Roche Vitamins Inc. | Method of making carotenoids |
WO2003072734A2 (en) * | 2002-02-25 | 2003-09-04 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
Non-Patent Citations (1)
Title |
---|
U. SCHWIETER, H. GUTMANN, H. LINDLAR, R. MARBET, N. RIGASSI, R. RÜEGG, S. F. SCHAEREN, O. ISLER: "Synthesen in der Carotinoid-Reihe 20. Mitteilung Neue Synthesen von Apocarotinoiden", HELVETICA CHIMICA ACTA, vol. 1, 1966, pages 369 - 390, XP002575142 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL185460A0 (en) | Trans carotenoids, their synthesis, formulation and uses | |
AU308121S (en) | Cosmetic product | |
AP2344A (en) | N-Thio-anthranilamid compounds and their use as pesticides. | |
IL191655A0 (en) | Novel compounds, their preparation and use | |
EP1917072A4 (en) | VITAMIN PREPARATION | |
EP1857091A4 (en) | COSMETIC | |
IL189856A0 (en) | New formulation | |
IL183740A0 (en) | Cyclohexylamides as dopamine d3, d2 and | |
TWI370115B (en) | New formulation | |
HK1116669A1 (en) | Cosmetic | |
AU308120S (en) | Cosmetic product | |
ZA200708807B (en) | Instant product | |
ZA200803407B (en) | Frangrance product, dispenser, and dispenser assembly | |
EP1961753A4 (en) | DERIVATIVES OF PIRAZOLOPYRIMIDINONE, THEIR PREPARATION AND USE | |
AU308122S (en) | Cosmetic product | |
AU308734S (en) | Cosmetic product | |
ZA200802276B (en) | Red lettuce | |
GB2428958B (en) | Snackfood product | |
GB0518129D0 (en) | Ramipril formulation | |
PT1876916E (pt) | Produto | |
GB0506263D0 (en) | Skin lightening methods, composition and products | |
GB0428247D0 (en) | Cosmetic product | |
GB0524520D0 (en) | Product | |
GB0504589D0 (en) | Product | |
GB0515480D0 (en) | Product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070919 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100517 |
|
17Q | First examination report despatched |
Effective date: 20111031 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20120511 |